Mauna Kea Technologies Appoints Molly O’Neill to Board of Directors

Mauna Kea Technologies specializes in designing, developing, and selling optical biopsy devices and tools. The group's products are intended for visualizing and detecting cellular abnormalities during the gastrointestinal and pulmonary endoscopic procedures, primarily in cancer patients. Net sales break down by activity as follows: - sale of licenses (40.7%); - sales of accessories (37.3%): mini-probes, software, etc.; - sales of system (11.2%); - services (10.8%). Net sales are distributed geographically as follows: Europe/Middle East/Africa (15.5%), the United States and Canada (42.9%) and Asia (41.6%).